<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Acute_pancreatitis%2Fen</id>
	<title>Acute pancreatitis/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Acute_pancreatitis%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Acute_pancreatitis/en&amp;action=history"/>
	<updated>2026-05-05T15:04:10Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Acute_pancreatitis/en&amp;diff=379774&amp;oldid=prev</id>
		<title>FuzzyBot: Updating to match new version of source page</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Acute_pancreatitis/en&amp;diff=379774&amp;oldid=prev"/>
		<updated>2026-01-06T17:32:51Z</updated>

		<summary type="html">&lt;p&gt;Updating to match new version of source page&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;languages/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
&lt;br /&gt;
[[File:Blausen 0699 PancreasAnatomy2.png|thumb|Pancreatic anatomy]]&lt;br /&gt;
*Acute inflammatory process that may involve surrounding tissue and remote organ systems&amp;lt;ref name=&amp;quot;NEJM&amp;gt; Whitcomb D. Acute Pancreatitis. N Engl J Med 2006; 354:2142-215&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Disease can range from mild inflammation to severe necrosis and multi-organ failure&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Etiology===&lt;br /&gt;
&lt;br /&gt;
*[[Special:MyLanguage/Symptomatic Cholelithiasis|Gallstones]] (including microlithiasis) - 35-40% of cases in most parts of the world &amp;lt;ref name=&amp;quot;NEJM&amp;quot;&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Special:MyLanguage/Alcohol|Alcohol]] (acute and chronic consumption) - 30% of cases in the US &amp;lt;ref&amp;gt;[https://www.uptodate.com/contents/etiology-of-acute-pancreatitis?search=pancreatitis%20etiology&amp;amp;source=search_result&amp;amp;selectedTitle=1~150&amp;amp;usage_type=default&amp;amp;display_rank=1 Vege SS. Etiology of acute pancreatitis. Uptodate.com]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Special:MyLanguage/Hypertriglyceridemia|Hypertriglyceridemia]]&lt;br /&gt;
*ERCP&lt;br /&gt;
**Most common post-ERCP complication, usually from mechanical injury from instrumentation of the pancreatic duct or hydrostatic injury from contrast injection&lt;br /&gt;
*Drugs ([[Special:MyLanguage/Azathioprine|Azathioprine]], cisplatin, [[Special:MyLanguage/furosemide|furosemide]], [[Special:MyLanguage/tetracycline|tetracycline]], thiazides, sulfa, [[Special:MyLanguage/valproate|valproate]], didanosine, pentamidine, etc)&lt;br /&gt;
*Autoimmune disease ([[Special:MyLanguage/Systemic Lupus Erythematosus|SLE]], [[Special:MyLanguage/Sjögren|Sjögren]], etc)&lt;br /&gt;
*[[Special:MyLanguage/Abdominal trauma|Abdominal trauma]]&lt;br /&gt;
*Postoperative complications&lt;br /&gt;
*Infection&lt;br /&gt;
**Bacterial: [[Special:MyLanguage/Legionella|Legionella]], [[Special:MyLanguage/Leptospirosis|Leptospirosis]], [[Special:MyLanguage/Mycoplasma pneumoniae|Mycoplasma]], [[Special:MyLanguage/Salmonella|Salmonella]]&lt;br /&gt;
**Viral: [[Special:MyLanguage/Mumps|Mumps]], [[Special:MyLanguage/coxsackie|coxsackie]], [[Special:MyLanguage/CMV|CMV]], echo, [[Special:MyLanguage/Viral hepatitis|Hep B]]&lt;br /&gt;
**Parasitic: [[Special:MyLanguage/ascaris|ascaris]], [[Special:MyLanguage/cryptosporidium|cryptosporidium]], [[Special:MyLanguage/toxoplasma|toxoplasma]]&lt;br /&gt;
*[[Special:MyLanguage/Hypercalcemia|Hypercalcemia]]&lt;br /&gt;
*[[Special:MyLanguage/Hyperparathyroidism|Hyperparathyroidism]]&lt;br /&gt;
*Ischemia&lt;br /&gt;
*[[Special:MyLanguage/PUD|Posterior penetrating ulcer]]&lt;br /&gt;
*[[Special:MyLanguage/Scorpions|Scorpion venom]] (Caused by the genre ''Tityus'' and ''Leiurus'' which are distributed in Central/South America and North/East Africa, respectively&lt;br /&gt;
*[[Special:MyLanguage/Organophosphate Toxicity|Organophosphate insecticide]]&lt;br /&gt;
*Pancreatic or ampullary tumor&lt;br /&gt;
*Pancreas divisum with ductular narrowing on pancreatogram&lt;br /&gt;
*Oddi sphincter dysfunction&lt;br /&gt;
*Idiopathic (15-20% of cases)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
&lt;br /&gt;
*[[Special:MyLanguage/Epigastric pain|Pain]] is the most common symptom and is often characterized by:&amp;lt;ref name=&amp;quot;NEJM&amp;quot;&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Persistent&lt;br /&gt;
**Localizes to epigastric area, around waist, RUQ, or occasionally LUQ&lt;br /&gt;
**Radiates to back&lt;br /&gt;
**The onset may be less abrupt and the pain poorly localized&lt;br /&gt;
*[[Special:MyLanguage/Nausea/vomiting|Nausea/vomiting]] noted in most&lt;br /&gt;
*Abdominal distention is frequent complaint&lt;br /&gt;
*[[Special:MyLanguage/Eponyms_(C-E)#Cullen.27s_sign|Cullen sign]] (ecchymosis of periumbilical region) - intrabdominal hemorrhage&lt;br /&gt;
*Turner sign (ecchymosis of flanks) - retroperitoneal hemorrhage&lt;br /&gt;
*Pulmonary Findings&lt;br /&gt;
**[[Special:MyLanguage/Hypoxemia|Hypoxemia]], [[Special:MyLanguage/ARDS|ARDS]], tachypnea&lt;br /&gt;
**Indicates severe pancreatitis&lt;br /&gt;
***Diaphragmatic inflammation, pancreatico-pleural fistula&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
&lt;br /&gt;
{{Abdominal Pain DDX Epigastric}}&lt;br /&gt;
&lt;br /&gt;
{{Abdominal Pain DDX Diffuse}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
&lt;br /&gt;
[[File:PMC4613590 JoU-2013-0017-g001.png|thumb|Ultrasound of acute pancreatitis with non-homogeneous, hypoechoic area in the body/tail projection attesting to extensive necrosis.]]&lt;br /&gt;
[[File:PMC4613590 JoU-2013-0017-g003.png|thumb|Complicated acute pancreatitis with large abscess in the projection of the tail.]]&lt;br /&gt;
[[File:Pankreatitis exsudativ CT axial.jpg|thumb|Acute exudative pancreatitis on CT scan]]&lt;br /&gt;
[[File:CalcifiedPanDucStoneandSomefluid.png|thumb|Pancreattis with calcified pancreatic duct stones with some free intra-abdominal fluid]]&lt;br /&gt;
&lt;br /&gt;
===Work-Up===&lt;br /&gt;
&lt;br /&gt;
*Lipase &lt;br /&gt;
**Amylase is both less sensitive and specific (sensitivity: 67-100%; specificity: 85-98%)&amp;lt;ref&amp;gt;Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol. 2002 Jun;97(6):1309-18.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*CBC&lt;br /&gt;
*Chemistry&lt;br /&gt;
*[[Special:MyLanguage/LFTs|LFTs]]&lt;br /&gt;
*?[[Special:MyLanguage/Lactate|Lactate]]&lt;br /&gt;
*?Triglyceride&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====[[Ultrasound: Abdomen|Ultrasound]]====&lt;br /&gt;
&lt;br /&gt;
*Edematous, swollen pancreas&lt;br /&gt;
*Gallstones&lt;br /&gt;
*Pseudocyst / pancreatic abscess&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====CT with IV contrast &amp;lt;ref&amp;gt;UK Working Party on Acute Pancreatitis. UK guidelines for the management of acute pancreatitis. Gut 2005;54:iii1-iii9 &amp;lt;/ref&amp;gt;====&lt;br /&gt;
&lt;br /&gt;
*Little utility early on in disease and unlikely to  affect the management of patients with acute pancreatitis during the first week of the illness&lt;br /&gt;
*Should be reserved for patients with persisting organ failure, severe pain and signs of sepsis&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
&lt;br /&gt;
Two of the following:&lt;br /&gt;
*Characteristic abdominal pain&lt;br /&gt;
*Lipase level &amp;gt;3x upper limit of normal&lt;br /&gt;
**Sensitivity 82-100%, specificity 82-100%&amp;lt;ref&amp;gt;Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol. 2002 Jun;97(6):1309-18.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Negative lipase does not exclude pancreatitis in chronic/recurrent disease&lt;br /&gt;
**Absolute value not associated with prognosis or severity&lt;br /&gt;
*Characteristic findings on [[Special:MyLanguage/ultrasound|ultrasound]] or CT&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
''The core treatment involves supportive care to rest the pancreas. This can be achieved mainly through diet control.''&lt;br /&gt;
&lt;br /&gt;
===Medical===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Diet====&lt;br /&gt;
&lt;br /&gt;
*NPO (clears is probably ok for mild/moderate cases)&lt;br /&gt;
*When restarting diet, eat small, low-fat meals and gradually advance over 3 to 6 days as tolerated&lt;br /&gt;
*In patients with mild pancreatitis who are tolerating POs and can most likely be discharged. Instructions regarding a light diet and avoidance of alcohol is necessary&amp;lt;ref name=&amp;quot;NEJM&amp;quot;&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====[[Special:MyLanguage/IV Fluids|IV Fluids]]====&lt;br /&gt;
&lt;br /&gt;
*[[Special:MyLanguage/Volume resuscitation|Volume resuscitation]] and constant monitoring of fluid status is important due to the risk of profound [[Special:MyLanguage/hypovolemia|hypovolemia]]&amp;lt;ref&amp;gt;Nathens AB, Curtis JR, Beale RJ, et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 2004;32:2524-2536&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Maintain urine output at 0.5 mL/kg&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====[[Special:MyLanguage/Analgesia|Analgesia]] and [[Special:MyLanguage/Antiemetics|Antiemetics]]====&lt;br /&gt;
&lt;br /&gt;
*For example:&lt;br /&gt;
**[[Special:MyLanguage/Dilaudid|Dilaudid]] 1mg or [[Special:MyLanguage/morphine|morphine]] 4mg IV PRN&lt;br /&gt;
**[[Special:MyLanguage/Zofran|Zofran]] 4mg IV PRN&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Electrolyte and Other Molecular Management====&lt;br /&gt;
&lt;br /&gt;
*Monitor for [[Special:MyLanguage/hypocalcemia|hypocalcemia]] and treat if symptomatic&lt;br /&gt;
*Monitor for development of [[Special:MyLanguage/hypoglycemia|hypoglycemia]] or [[Special:MyLanguage/hyperglycemia|hyperglycemia]]&lt;br /&gt;
*Consider albumin replacement if level &amp;lt;2g/dL&lt;br /&gt;
*See [[Special:MyLanguage/hypertriglyceridemia|hypertriglyceridemia]] for management of high triglycerides&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====[[Special:MyLanguage/Antibiotics|Antibiotics]]====&lt;br /&gt;
&lt;br /&gt;
''Antibiotic use is often controversial and generally only required if there are obvious signs or sources of infection. Prophylactic use is not necessary&amp;lt;ref&amp;gt;Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev.2003; Issue 4, CD002941.&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg. 1998;2:496–503.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sharma VK, Howden CW. Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas. 2001;22:28–31&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Zhou YM, Xue ZL, Li YM, et al. Antibiotic prophylaxis in patients with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2005;4:23–27&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Manes G, Rabitti PG, Menchise A, et al. Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas. 2003;27:79–83&amp;lt;/ref&amp;gt;''&lt;br /&gt;
*Only indicated for necrosis, abscess, or infected pseudocyst / peripancreatic fluid&lt;br /&gt;
*[[Special:MyLanguage/Imipenem-cilastatin|Imipenem-cilastatin]], [[Special:MyLanguage/meropenem|meropenem]], or ([[Special:MyLanguage/fluoroquinolone|fluoroquinolone]] + [[Special:MyLanguage/metronidazole|metronidazole]])&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Procedural/Surgical===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Bowel Decompression====&lt;br /&gt;
&lt;br /&gt;
*Consider placement of an [[Special:MyLanguage/NG tube|NG tube]] only if [[Special:MyLanguage/SBO|SBO]] or [[Special:MyLanguage/ileus|ileus]] is present and symptomatic&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====ERCP&amp;lt;ref&amp;gt;Tenner, S., Baillie, J., DeWitt, J. and Vege, S. (2013). American College of Gastroenterology Guideline: Management of Acute Pancreatitis. The American Journal of Gastroenterology, 108(9), pp.1400-1415.&amp;lt;/ref&amp;gt;====&lt;br /&gt;
&lt;br /&gt;
*Indicated for patients with gallstone pancreatitis with retained CBD stone or cholangitis (recommended within 24 hours)&lt;br /&gt;
*Alternative option for patients with gallstone pancreatitis who are poor operative candidates for cholecystectomy&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Cholecystectomy====&lt;br /&gt;
&lt;br /&gt;
*Indicated for patients with biliary pancreatitis. Patients will generally will benefit from early cholecystectomy, as soon as the patient has recovered, preferably within the same hospital admission.&amp;lt;ref&amp;gt;Kimura Y, Takada T, Kawarada Y et al. JPN Guidelines for the management of acute pancreatitis: treatment of gallstone-induced acute pancreatitis. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779396/ J Hepatobiliary Pancreat Surg. 2006;13(1):56-60.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Fluid Collection Drainage====&lt;br /&gt;
&lt;br /&gt;
*Symptomatic walled-off pancreatic fluid collections should be evaluated for a drainage procedure.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Discharge===&lt;br /&gt;
&lt;br /&gt;
*Mild case + no biliary disease + no systemic complication + tolerating clears&lt;br /&gt;
*Patients can be discharged when oral analgesics control their pain&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Admit===&lt;br /&gt;
&lt;br /&gt;
*All other patients&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Complications==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Local===&lt;br /&gt;
&lt;br /&gt;
*Pancreatic necrosis&lt;br /&gt;
*Pancreatic pseudocyst / abscess&lt;br /&gt;
*Portal vein thrombosis&lt;br /&gt;
*[[Special:MyLanguage/Abdominal compartment syndrome|Abdominal compartment syndrome]]&lt;br /&gt;
*Abdominal pseudoaneurysm&lt;br /&gt;
*Intra Abdominal hemorrhage&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Systemic===&lt;br /&gt;
&lt;br /&gt;
*Cardiac dysfunction&lt;br /&gt;
*[[Special:MyLanguage/Renal failure|Renal failure]]&lt;br /&gt;
*[[Special:MyLanguage/Respiratory failure|Respiratory failure]]&lt;br /&gt;
*[[Special:MyLanguage/Shock|Shock]] &lt;br /&gt;
*[[Special:MyLanguage/Hypocalcemia|Hypocalcemia]] (due to sequestration in necrotic fat)&lt;br /&gt;
*[[Special:MyLanguage/Hyperglycemia|Hyperglycemia]]&lt;br /&gt;
*[[Special:MyLanguage/Pleural effusion|Pleural effusion]] with high amylase&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Prognosis==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===APACHE-II===&lt;br /&gt;
&lt;br /&gt;
*Highest sensitivity and specificity in distinguishing mild from severe pancreatitis&amp;lt;ref&amp;gt;Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Can be used to estimate the risk of ICU mortality based on worse set of labs during a patient's first 24hrs&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===CT Severity Index===&lt;br /&gt;
&lt;br /&gt;
A extension of the Balthazar score with stratification of severity based on score.&amp;lt;ref&amp;gt;Balthazar EJ, Robinson DL, Megibow AJ et-al. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990;174 (2): 331-6&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology. 2002;223 (3): 603-13[http://pubs.rsna.org/doi/pdf/10.1148/radiol.2233010680 PDF]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*;Balthazar grading of pancreatitis&lt;br /&gt;
:'''A''' = normal pancreas - 0&lt;br /&gt;
:'''B''' = enlargement of pancreas - 1&lt;br /&gt;
:'''C''' = inflammatory changes in pancreas and peripancreatic fat - 2&lt;br /&gt;
:'''D''' = ill defined single fluid collection - 3&lt;br /&gt;
:'''E''' = two or more poorly defined fluid collections - 4&lt;br /&gt;
&lt;br /&gt;
*;Pancreatic necrosis &lt;br /&gt;
:none - 0&lt;br /&gt;
:less than/equal to 30% - 2&lt;br /&gt;
:&amp;gt; 30-50 % - 4&lt;br /&gt;
:&amp;gt; 50% - 6&lt;br /&gt;
&lt;br /&gt;
*;The maximum score that can be obtained is 10.&lt;br /&gt;
:0-3: mild&lt;br /&gt;
:4-6: moderate&lt;br /&gt;
:7-10: severe&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Ranson criteria===&lt;br /&gt;
&lt;br /&gt;
*Consist of 11 parameters. Five of the factors are assessed at admission, and six of the factors are assessed during the next 48 hours. &amp;lt;ref&amp;gt;Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974 Jul;139(1):69-81. PubMed PMID: 4834279&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Score of 3 or more indicates severe acute pancreatitis.&lt;br /&gt;
;On admission:&lt;br /&gt;
#Age &amp;gt; 55 &lt;br /&gt;
#WBC &amp;gt; 16,000&lt;br /&gt;
#Blood glucose &amp;gt;200mg/dL&lt;br /&gt;
#Lactate dehydrogenase &amp;gt;350 U/L&lt;br /&gt;
#Aspartate aminotransferase (AST) &amp;gt;250 U/L&lt;br /&gt;
;48 hours:&lt;br /&gt;
#Hematocrit fall by &amp;gt; 10%&lt;br /&gt;
#BUN increase by &amp;gt;5mg/dL&lt;br /&gt;
#Serum Calcium &amp;lt;8mg/dL&lt;br /&gt;
#pO2 &amp;lt; 60mmHg&lt;br /&gt;
#Base deficit &amp;gt;4 MEq/L&lt;br /&gt;
#Fluid Sequestation &amp;gt; 6L&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===BISAP===&lt;br /&gt;
&lt;br /&gt;
*Bedside Index for Severity in Acute Pancreatitis&amp;lt;ref&amp;gt;Wu BU et al. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008 Dec;57(12):1698-703.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Decreased sensitivity, but outperforms in specificity as compared to Ranson and APACHE II&amp;lt;ref&amp;gt;Gao W et al. The Value of BISAP Score for Predicting Mortality and Severity in Acute Pancreatitis: A Systematic Review and Meta-Analysis. PLoS One. 2015; 10(6): e0130412.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Papachristou GI et al. Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol. 2010 Feb;105(2):435-41; quiz 442.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Clinically more manageable to obtain, especially in the ED setting&lt;br /&gt;
**BUN &amp;gt; 25 mg/dL&lt;br /&gt;
**Impaired mental status, defined as disorientation, lethargy, somnolence&lt;br /&gt;
**≥2 SIRS Criteria&lt;br /&gt;
**Age &amp;gt; 60 years&lt;br /&gt;
**Pleural effusion&lt;br /&gt;
*Interpretation&lt;br /&gt;
**Score of 0-2 had mortality &amp;lt; 2%&lt;br /&gt;
**Score of 3-4 has mortality &amp;gt; 15%&lt;br /&gt;
**Score of 5 has 22% mortality&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
*[[Special:MyLanguage/Pancreatitis Guidelines|Pancreatitis Guidelines]]&lt;br /&gt;
*[[Special:MyLanguage/Chronic pancreatitis|Chronic pancreatitis]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
&lt;br /&gt;
*[http://www.mdcalc.com/ransons-criteria-for-pancreatitis-mortality/ MDCalc - Ranson's Criteria]&lt;br /&gt;
*[https://www.mdcalc.com/apache-ii-score/ MDCalc - Apache II Score]&lt;br /&gt;
*[http://www.mdcalc.com/bisap-score-for-pancreatitis-mortality/ MDCalc - BISAP Score for Pancreatitis Mortality]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:GI]]&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>